TG Therapeutics
TGTX
TGTX
115 hedge funds and large institutions have $272M invested in TG Therapeutics in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 43 increasing their positions, 27 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
4.25% less ownership
Funds ownership: 55.31% → 51.06% (-4.2%)
37% less capital invested
Capital invested by funds: $434M → $272M (-$162M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
115
Holding in Top 10
–
Calls
$8.3M
Puts
$2.19M
Top Buyers
| 1 | +$12.1M | |
| 2 | +$2.65M | |
| 3 | +$1.99M | |
| 4 |
BlackRock
New York
|
+$1.7M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.22M |
Top Sellers
| 1 | -$8.65M | |
| 2 | -$7.41M | |
| 3 | -$6.07M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$5.96M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.8M |